| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.061 | 0.9 |